Discussion stirs around Motif Bio PLC (LON:MTFB) this week; here is what analysts are saying.

October 13, 2017 - By Clifton Ray

 Discussion stirs around Motif Bio PLC (LON:MTFB) this week; here is what analysts are saying.

Motif Bio PLC (LON:MTFB) Ratings Coverage

Among 4 analysts covering Motif Bio Plc (LON:MTFB), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Motif Bio Plc had 71 analyst reports since July 23, 2015 according to SRatingsIntel. The company was maintained on Wednesday, September 30 by Beaufort Securities. The rating was maintained by Northland Capital with “Buy” on Tuesday, November 24. Beaufort Securities maintained it with “Speculative Buy” rating and GBX 110 target in Wednesday, December 16 report. FinnCap maintained Motif Bio PLC (LON:MTFB) on Wednesday, June 7 with “Buy” rating. Beaufort Securities maintained the stock with “Speculative Buy” rating in Wednesday, October 14 report. Northland Capital maintained Motif Bio PLC (LON:MTFB) rating on Wednesday, January 18. Northland Capital has “Buy” rating and GBX 90 target. The company was maintained on Tuesday, August 25 by Beaufort Securities. FinnCap maintained it with “Buy” rating and GBX 100 target in Wednesday, August 9 report. Northland Capital maintained it with “Buy” rating and GBX 114 target in Tuesday, December 15 report. Northland Capital maintained the shares of MTFB in report on Thursday, August 27 with “Buy” rating. Below is a list of Motif Bio PLC (LON:MTFB) latest ratings and price target changes.

06/10/2017 Broker: Northland Capital Rating: Buy Maintain
05/10/2017 Broker: Beaufort Securities Rating: Speculative Buy Old Target: GBX 110.00 New Target: GBX 110.00 Maintain
05/10/2017 Broker: Peel Hunt Rating: Buy New Target: GBX 106.00 Initiates Starts
04/10/2017 Broker: Northland Capital Rating: Buy Maintain
04/10/2017 Broker: FinnCap Rating: Buy Old Target: GBX 100.00 New Target: GBX 100.00 Maintain
02/10/2017 Broker: Beaufort Securities Rating: Speculative Buy Old Target: GBX 110.00 New Target: GBX 110.00 Maintain
29/09/2017 Broker: Northland Capital Rating: Buy Maintain
18/09/2017 Broker: Northland Capital Rating: Buy Maintain
24/08/2017 Broker: FinnCap Rating: Buy Old Target: GBX 100.00 Maintain
09/08/2017 Broker: Northland Capital Rating: Buy Maintain

The stock increased 7.01% or GBX 2.75 on October 13, reaching GBX 42. About 979,377 shares traded or 28.31% up from the average. Motif Bio PLC (LON:MTFB) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.

Motif Bio plc is a clinical-stage biopharmaceutical company. The company has market cap of 110.19 million GBP. The Firm is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It currently has negative earnings. It operates in the development and commercialization of pharmaceutical formulations segment.

Another recent and important Motif Bio PLC (LON:MTFB) news was published by Globenewswire.com which published an article titled: “Motif Bio to present at upcoming investor and scientific conferences” on August 31, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.